Catalyst Wire Dossier Catalyst Wire Dossier

JADENU

deferasirox · Novartis Pharmaceuticals Corporation
Drug timelines are a Plus or Pro feature.

21 regulatory and trial events tracked for JADENU, covering 2015-03-30 to 2022-02-11. Get the full timeline:

Most recent: FDA Approved: JADENU — Supplemental Application (Novartis Pharmaceuticals Corporation)

See pricing